[1]
F. F. de Oliveira, J. M. Berretta, E. S. Chen, M. C. Smith, and P. H. F. Bertolucci, “Pharmacogenetic effects of angiotensin-converting enzyme inhibitors over age-related urea and creatinine variations in patients with dementia due to Alzheimer disease”, Colomb Med, vol. 47, no. 2, pp. 76–80, Jun. 2016.